• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Services
    • Subscriptions
    • Customised research
    • Shop
    • Telephone conference consultancy
  • Geography
    • Europe
    • Africa
    • Oceania
    • Americas
    • Asia
  • Resources
    • Podcasts

      Interviews

    • Industry events

      What’s coming up

    • Blogs

      Topical articles on current issues

    • Coffee & Cannabis

      Exclusive private conference

  • About us
    • Why CannIntelligence?
    • Tamarind Intelligence Group
    • CannIntelligence training center
Logo
Login LoginLogin Free Trial Free TrialFree Trial
  • Services
    • Subscriptions
    • Customised research
    • Shop
    • Telephone conference consultancy
  • Geography
    • Europe
    • Africa
    • Oceania
    • Americas
    • Asia
  • Resources
    • Podcasts

      Interviews

    • Industry events

      What’s coming up

    • Blogs

      Topical articles on current issues

    • Coffee & Cannabis

      Exclusive private conference

  • About us
    • Why CannIntelligence?
    • Tamarind Intelligence Group
    • CannIntelligence training center

    More results...

    Filter by Content types
    Regulatory databases
    Regulatory reports
    Market reports
    News analysis
    Filter by Geography
    Africa
    Asia
    Australasia
    Europe
    United Kingdom
    North America
    United States
    South America

    Alerts LATEST ALERTS

    • Canada Canadian Tobacco and Nicotine Survey 2022 results published…
    • Italy Decree classifying CBD as medicinal comes into force today…
    • Netherlands Updated timeline of cannabis experiment published…
    • Slovenia HHC, HHC-O, HHCP and THCP may be added to the narcotics list…
    • Czech Republic Call to combat addiction with proportional regulation, not bans…
    • Guyana Hemp trial cultivation to start in early 2024…
    • Netherlands Cannabis experiment startup phase to begin 15th December…
    • United States Senate just might pass SAFE Banking Act this time…
    • Iceland Companies fined for promoting medicinal effects of CBD cosmetics…
    • Israel Medical Cannabis Unit publishes draft table on product categories…
    • Ukraine Bill on legalising medical cannabis heads for second reading…
    • Slovenia Parliamentary question raised about cannabis working group’s progress…
    View all

    No results, please use the search bar to make a different search

    Latest content

    • Netherlands CBD insights dashboard, 2023
    • US CBD insights dashboard, 2023
    • Italy CBD insights dashboard, 2023
    • Switzerland CBD insights dashboard, 2023
    • Skinny Rebel without a cause? ASA rules on UK drink’s name, not CBD health claim

    Sign up to our newsletter

    Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


      See more


      By signing up you agree to our Privacy Policy. 

      Twitter Linkedin Youtube
      • Products and Services
        • Subscriptions
        • Shop
        • Customised Research
        • Telephone conference consultancy
      • About us
        • About CannIntelligence
        • Our services
        • Who we are
        • Media
        • Jobs
        • Contact us
        • Tamarind Intelligence Group
      © 2023 Tamarind Media Limited (T/A CannIntelligence)

      CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.

      • Contact us
      • Terms & Conditions

      Start your FREE trial

      Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.

      Your display name will appear here.
      Please enter a username.
      Account Info
      A password will be e-mailed to you.
      Hide from Public
      Hide from Public
      Please add a phone country prefix
      Hide from Public
      Hide from Public
      Hide from Public
      Hide from Public
      Hide from Public
      I agree to Terms and Conditions.

      START TRIAL

      By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.